Colorectal cancer screening: Efficiency and effectiveness

Health Economics

Volumn 7, Issue 1, 1998, Pages 9-20

  Gyrd Hansen, Dorte ^a,c   Søgaard, Jes ^a   Kronborg, Ole ^b  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

^c Centre for Health and Social Policy   (Denmark)

Author keywords

Colorectal cancer; Cost effectiveness; Economic evaluation; Model simulation; Screening

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SCREENING; COLORECTAL CANCER; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DATA ANALYSIS; DENMARK; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; OCCULT BLOOD; PRIORITY JOURNAL;

AGED; COLORECTAL NEOPLASMS; COMPUTER SIMULATION; COST-BENEFIT ANALYSIS; DENMARK; EFFICIENCY, ORGANIZATIONAL; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; MODELS, ECONOMETRIC; OCCULT BLOOD; REPRODUCIBILITY OF RESULTS; SURVIVAL RATE;

EID: 0031891613     PISSN: 10579230     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1050(199802)7:1<9::AID-HEC304>3.0.CO;2-H     Document Type: Article

References (32)

1. Hardcastle, J., Chamberlain, J., Robinson, M., et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996; 348: 1472-1477.
2. Fujita, M., Sugiyama, R., Kuminashi, Y., et al. Evaluation of effectiveness of mass screening for colorectal cancer. World Journal of Surgery 1990; 14: 648-653.
3. Allison, J. E. and Feldman, R. Cost benefits of Hemoccult screening for colorectal cancer. Digestive Diseases and Sciences 1985; 30(9): 860-865.
4. Gnauck, R. Screening for colon cancer in Germany. Tumori 1995; 81 (Suppl.): 30-.
5. Carstensen B., et al. (eds). Survival of Danish Cancer Patients 1943-1987. Copenhagen: Danish Cancer Society Division for Cancer Epidemiology, Kræftens Bekæmpelse, Munkgaard, 1993.
6. Day, N. E. and Walter, S. D. Simplified models for screening for chronic disease: Estimation procedures for mass screening programmes. Biometrics 1984; 40: 1-14.
7. Kronborg, O., et al. Initial mass screening for colorectal cancer with fecal occult blood test. A prospective randomized study at Funen in Denmark. Scandinavian Journal of Gastroenterology 1987; 22: 677-686.
8. Kronborg, O. Population screening for colorectal cancer, the goals and means. Annals of Medicine 1991; 23: 373-379.
9. Kronborg, O. Screening guidelines for colorectal cancer. Scandinavian Journal of Gastroenterology 1992; 27 (Suppl. 192):123-129.
10. Kronborg, O., Fenger, C., Olsen, J., Jørgensen, O. D. and Søndergaard, O. A randomised study of screening for colorectal cancer with fecal occult blood test at Funen in Denmark. The Lancet 1996; 348: 1467-1471.
11. Gyrd-Hansen, D., Søgaard, J. and Kronborg, O. Analysis of screening data: colorectal cancer. International Journal of Epidemiology 1997; in press.
12. Stryker, S. J., et al. Natural history of untreated colonic polyps. Gastroenterology 1987; 93: 1009-1013.
13. Jørgensen, O. D., et al. The Funen adenoma follow-up study. Incidence and death from colorectal carcinoma in an adenoma surveillance program. Scandinavian Journal of Gastroenterology 1993; 28: 869-874.
14. Whynes, D. K., et al. Colorectal cancer screening and quality of iife. Quality of Life Research 1994; 3: 191-198.
15. Bech, K. and Kronborg, O. Hospital stay following screening for colorectal cancer. The first 5 years of a randomised trial. Ugeskrift for Lœger 1992; 154: 696-699.
16. Tuck, J., et al. Screening and the cost of treating colorectal cancer: some preliminary results. Public Health 1989; 103: 413-419.
17. Whynes, D. K, Walker, A. R., Chamberlain, J. O. and Hardcastle, J. D. Screening and the costs of treating colorectal cancer. British Journal of Cancer 1993; 68: 965-968.
18. Gyrd-Hansen, D., Søgaard, J. and Kronborg, O. Analysing Colorectal Screening Data Using A Mathematical Model. CHS Working Paper 1996:9. Odense: Odense University, 1996.
19. Walker, A., et al. The cost of screening for colorectal cancer. Journal of Epidemiology and Community Health 1991; 45: 220-224.
20. Office of Technology Assessment (OTA). Costs and effectiveness of colorectal cancer screening in the elderly. A Background Paper in OTA's Series on Preventive Health Services Under Medicare. September 1990.
21. Eddy, D. M. Screening for colorectal cancer. Annals of Internal Medicine 1990; 113: 373-384.
22. Hillman, A. L. and Kim, M. S. Economic decision making in health care. Pharmacoeconomics 1996; 7(3): 198-205.
23. Gold, M. R., Siegel, J. E., Russell, L. B. and Weinstein, M. C. (eds). Cost-Effectiveness in Health and Medicine. New York: Oxford University Press, 1996.
24. Garber, A. M. and Phelps, C. E. Economic foundations of cost-effectiveness analysis. Journal of Health Economics 1997; 16(1): 1-31.
25. Meltzer, D. Accounting for future costs in medical cost-effectiveness analysis. Journal of Health Economics 1997; 16(1): 33-64.
26. Weinstein, M. C. and Manning, W. G., Jr. Theoretical issues in cost-effectiveness analysis. Journal of Health Economics 1997; 16(1): 121-128.
27. Sørensen L. H. Det Aldersfordelte Brug af Sundhedsydelser (The Age-Distributed Use of Health Care Resources. In Danish). CHS Working Paper 1996:10. Odense: Odense University, 1996.
28. Wagner, J. L., Tunis, S., Brown, M., Ching, A., and Almeida, R. Cost-effectiveness of colorectal cancer screening in average-risk adults. In: Young, G. P., Rozen, P. and Levin, B. (eds) Prevention and Early Detection of Colorectal Cancer, Chapt. 19. Philadelphia: W. B. Saunders, 1996.
29. Byers, T. and Gorsky, R. Estimates of costs and effects of screening for colorectal cancer in the United States. Cancer 1992; 70: 1288-1294.
30. Søgaard, J. and Gyrd-Hansen, D. Counting and Discounting Gained Life-Years in Cost-Effectiveness Analysis: Different Methods and Different Results. CHS Working Paper 1996:4. Odense: University of Odense, 1996.
31. Sundhedsstyrelsen, 1994. Brystkræft. Tidlig Opsporing og Undersøgelse. Redegørelse. Sundhedsstyrelsens udvalg vedrørende tidlig opsporing og undersøgelse af lidelser i brystet. In Danish.
32. Gyrd-Hansen, D., Hølund, B. and Andersen, P. A Cost-effectiveness analysis of screening against cervical cancer. Health policy implications. Health Policy. 1995; 34: 35-51.